一种新型的挥发性葡萄藻类生物合成抑制剂,用于对抗黄金葡萄球菌
Joydeep Singha1, Nipu Dutta2, Jyoti Prasad Saikia1
1Department of Molecular Biology and Biotechnology, Tezpur University, Tezpur, Assam, India.
Microbial pathogenesis
|March 17, 2025
概括
来自大/油杂的挥发性有机化合物通过降低细菌耐药性和稳素生产来增强对S. aureus的抗生素有效性. 这表明GMM作为S. aureus感染的辅助疗法的潜力.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
背景情况:
- 黄金葡萄球菌 (S. aureus) 的抗生素耐药性对全球健康构成重大威胁.
- 稳素生产是导致S. aureus抗生素耐药性的关键机制.
- 正在探索天然化合物作为克服抗生素耐药性的潜在辅助剂.
研究的目的:
- 研究来自大/油杂 (GMM) 的挥发性有机化合物 (VOC) 对抗黄金菌抗生素抗菌活性的影响.
- 阐明转基因转基因挥发性有机物增强抗生素敏感性的机制,特别侧重于稳素生产.
- 为了确定负责这些影响的GMM挥发性有机化合物中的关键化合物.
主要方法:
- 制备大/油杂 (GMM) 和提取其挥发性有机化合物 (VOC).
- 对基因转基因有机物挥发性有机物的影响评估,对 gentamycin,kanamycin 和 streptomycin 对黄金色杆菌的抗菌活性.
- 用转基因转基因有机物VOCs处理的金黄色菌中葡萄藻类生产量的量化.
- 使用气体染色体质谱法 (GC-MS) 识别转基因菌中的主要VOC.
- 在分析的VOC结合亲缘关系到脱氧二烯合成酶 (crtM).
- 用富里埃转换红外光谱学和扫描电子显微镜验证S. aureus膜流动性的变化.
主要成果:
- 转基因转基因挥发性有机化合物显著增强了对S. aureus.的抗菌活性 (41.17%),卡纳米辛 (38.89%) 和链杆菌素 (43.75%) 的抗菌活性.
- 仅仅转基因转基因的挥发性有机化合物,就减少了S. aureus.中的稳素生产44.23%.
- 确定的主要挥发性有机物包括氨酸,阿烯,乙烯二,烯二酸盐 (AITC) 和sinigrin,其中sinigrin对crtM具有最高的结合亲和力.
- 减少的稳素生产导致细菌膜流动性增加,促进了抗生素的进入.
结论:
- 来自GMM的VOC具有强大的抗菌增强特性,可以对抗S. aureus.
- 转基因转基因挥发性有机物有效地抑制了稳素的产生,这是S. aureus抗生素耐药性的关键机制.
- 确定的VOCs,特别是sinigrin,ajoene和allicin,可能是观察到的影响的原因.
- 转基因转基因挥发性有机物显示出作为一种辅助疗法的显著潜力,用于对抗金黄色细菌感染并克服抗生素耐药性.
关键词:
2-乙烯-4H-1,3,表示它们是什么.添加到一个Ajoene.大/末油的油.马酸盐是什么 马酸盐是什么黄金葡萄球菌黄金葡萄球菌葡萄糖酸盐 (Staphyloxanthin) 是一种葡萄糖酸盐 (Staphyloxanthin) 的一种.更多相关视频
相关概念视频
Gene Regulation in Microbial Communities: Quorum Sensing
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...


